Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation.

Cohen OS, Prohovnik I, Korczyn AD, Inzelberg R, Nitsan Z, Appel S, Kahana E, Rosenmann H, Chapman J.

Isr Med Assoc J. 2012 Mar;14(3):162-5.

2.

Cerebral white matter disruption in Creutzfeldt-Jakob disease.

Lee H, Cohen OS, Rosenmann H, Hoffmann C, Kingsley PB, Korczyn AD, Chapman J, Prohovnik I.

AJNR Am J Neuroradiol. 2012 Nov;33(10):1945-50. doi: 10.3174/ajnr.A3125. Epub 2012 May 10.

3.

The EEG in E200K familial CJD: relation to MRI patterns.

Appel SA, Chapman J, Prohovnik I, Hoffman C, Cohen OS, Blatt I.

J Neurol. 2012 Mar;259(3):491-6. doi: 10.1007/s00415-011-6208-5. Epub 2011 Aug 12.

PMID:
21833705
4.

Hypertension impairs vascular reactivity in the pediatric brain.

Wong LJ, Kupferman JC, Prohovnik I, Kirkham FJ, Goodman S, Paterno K, Sharma M, Brosgol Y, Pavlakis SG.

Stroke. 2011 Jul;42(7):1834-8. doi: 10.1161/STROKEAHA.110.607606. Epub 2011 May 26.

PMID:
21617149
5.

The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.

Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, Rosenmann H, Kahana E, Chapman J.

Acta Neurol Scand. 2011 Dec;124(6):368-74. doi: 10.1111/j.1600-0404.2011.01489.x. Epub 2011 Feb 8.

6.

(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.

Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.

Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696.

7.

Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology.

Cohen OS, Chapman J, Lee H, Nitsan Z, Appel S, Hoffman C, Rosenmann H, Korczyn AD, Prohovnik I.

J Neurol. 2011 Jan;258(1):89-95. doi: 10.1007/s00415-010-5694-1. Epub 2010 Aug 21.

PMID:
20725737
8.

The effects of hypertension on the paediatric brain: a justifiable concern.

Sharma M, Kupferman JC, Brosgol Y, Paterno K, Goodman S, Prohovnik I, Kirkham FJ, Pavlakis SG.

Lancet Neurol. 2010 Sep;9(9):933-40. doi: 10.1016/S1474-4422(10)70167-8. Epub 2010 Jul 30.

PMID:
20675195
9.

Web-based multi-center data management system for clinical neuroscience research.

Pozamantir A, Lee H, Chapman J, Prohovnik I.

J Med Syst. 2010 Feb;34(1):25-33.

PMID:
20192052
10.

Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever.

Appel SA, Chapman J, Kahana E, Rosenmann H, Prohovnik I, Pras E, Reznik-Wolf H, Cohen OS.

Eur J Neurol. 2010 Jun 1;17(6):861-5. doi: 10.1111/j.1468-1331.2010.02948.x. Epub 2010 Jan 20.

11.

Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease.

Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I.

J Neurol Sci. 2010 Jan 15;288(1-2):129-34. doi: 10.1016/j.jns.2009.09.019. Epub 2009 Oct 13.

12.

Enhanced detection of diffusion reductions in Creutzfeldt-Jakob disease at a higher B factor.

Lee H, Hoffman C, Kingsley PB, Degnan A, Cohen O, Prohovnik I.

AJNR Am J Neuroradiol. 2010 Jan;31(1):49-54. doi: 10.3174/ajnr.A1756. Epub 2009 Sep 12.

13.

MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease.

Cohen OS, Hoffmann C, Lee H, Chapman J, Fulbright RK, Prohovnik I.

Cerebellum. 2009 Sep;8(3):373-81. doi: 10.1007/s12311-009-0106-8. Epub 2009 May 1.

PMID:
19408064
14.

Neural correlates of emotion processing in borderline personality disorder.

Koenigsberg HW, Siever LJ, Lee H, Pizzarello S, New AS, Goodman M, Cheng H, Flory J, Prohovnik I.

Psychiatry Res. 2009 Jun 30;172(3):192-9. doi: 10.1016/j.pscychresns.2008.07.010. Epub 2009 Apr 24.

15.

Memory activation in healthy nonagenarians.

Beeri MS, Lee H, Cheng H, Wollman D, Silverman JM, Prohovnik I.

Neurobiol Aging. 2011 Mar;32(3):515-23. doi: 10.1016/j.neurobiolaging.2009.02.022. Epub 2009 Apr 1.

16.

Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, Kahana E, Korczyn AD, Prohovnik I.

Brain. 2009 Oct;132(Pt 10):2680-7. doi: 10.1093/brain/awp064. Epub 2009 Mar 24.

17.

Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.

Prohovnik I, Hurlet-Jensen A, Adams R, De Vivo D, Pavlakis SG.

J Cereb Blood Flow Metab. 2009 Apr;29(4):803-10. doi: 10.1038/jcbfm.2009.6. Epub 2009 Feb 11.

PMID:
19209182
18.

Cross-validation of brain segmentation by SPM5 and SIENAX.

Lee H, Prohovnik I.

Psychiatry Res. 2008 Nov 30;164(2):172-7. doi: 10.1016/j.pscychresns.2007.12.008. Epub 2008 Oct 18.

19.

MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study.

Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1638-43. doi: 10.3174/ajnr.A1217. Epub 2008 Jul 17.

20.

Number of children is associated with neuropathology of Alzheimer's disease in women.

Beeri MS, Rapp M, Schmeidler J, Reichenberg A, Purohit DP, Perl DP, Grossman HT, Prohovnik I, Haroutunian V, Silverman JM.

Neurobiol Aging. 2009 Aug;30(8):1184-91. Epub 2008 Jan 10.

21.

Cerebrovascular effects of hemodialysis in chronic kidney disease.

Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E.

J Cereb Blood Flow Metab. 2007 Nov;27(11):1861-9. Epub 2007 Apr 4.

PMID:
17406658
22.

The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation.

Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I.

Magn Reson Imaging. 2006 Nov;24(9):1121-9. Epub 2006 Sep 7.

PMID:
17071334
23.

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.

Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V.

Neurology. 2006 Jan 10;66(1):49-55.

PMID:
16401845
24.

Functional MRI changes before and after onset of reported emotions.

Prohovnik I, Skudlarski P, Fulbright RK, Gore JC, Wexler BE.

Psychiatry Res. 2004 Dec 30;132(3):239-50.

PMID:
15664795
25.

Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.

Mosconi L, Herholz K, Prohovnik I, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Sorbi S, Pupi A.

J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):15-23.

26.

Tolerance of MRI procedures by the oldest old.

Wollman DE, Beeri MS, Weinberger M, Cheng H, Silverman JM, Prohovnik I.

Magn Reson Imaging. 2004 Nov;22(9):1299-304.

PMID:
15607102
27.

Regional cerebral blood flow and cognitive deficits in chronic lyme disease.

Fallon BA, Keilp J, Prohovnik I, Heertum RV, Mann JJ.

J Neuropsychiatry Clin Neurosci. 2003 Summer;15(3):326-32.

PMID:
12928508
28.

Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease.

Wollman DE, Prohovnik I.

Dialogues Clin Neurosci. 2003 Mar;5(1):89-99.

29.

Increased cerebral blood flow after brain arteriovenous malformation resection is substantially independent of changes in cardiac output.

Hashimoto T, Young WL, Prohovnik I, Gupta DK, Ostapkovich ND, Ornstein E, Halim AX, Quick CM.

J Neurosurg Anesthesiol. 2002 Jul;14(3):204-8.

PMID:
12172292
30.

Sickle cell disease: the neurological complications.

Prengler M, Pavlakis SG, Prohovnik I, Adams RJ.

Ann Neurol. 2002 May;51(5):543-52. Review.

PMID:
12112099
31.

Functional magnetic resonance imaging of cocaine craving.

Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, Gore JC.

Am J Psychiatry. 2001 Jan;158(1):86-95.

PMID:
11136638
32.

Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression.

Nobler MS, Roose SP, Prohovnik I, Moeller JR, Louie J, Van Heertum RL, Sackeim HA.

Am J Geriatr Psychiatry. 2000 Fall;8(4):289-96.

PMID:
11069268
33.

Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia.

Pavlakis SG, Kingsley PB, Harper R, Buckwald S, Spinazzola R, Frank Y, Prohovnik I.

Arch Neurol. 1999 Dec;56(12):1476-81.

PMID:
10593302
34.

Cerebral blood flow patterns underlying the differential impairment in category vs letter fluency in Alzheimer's disease.

Keilp JG, Gorlyn M, Alexander GE, Stern Y, Prohovnik I.

Neuropsychologia. 1999 Oct;37(11):1251-61.

PMID:
10530725
35.

Validation of a Hebrew selective reminding test.

Gigi A, Schnaider-Beeri M, Davidson M, Prohovnik I.

Isr J Psychiatry Relat Sci. 1999;36(1):11-7.

PMID:
10389358
36.

Senile degeneration and cognitive impairment in chronic schizophrenia.

Dwork AJ, Susser ES, Keilp J, Waniek C, Liu D, Kaufman M, Zemishlany Z, Prohovnik I.

Am J Psychiatry. 1998 Nov;155(11):1536-43.

PMID:
9812114
37.

Iodine-123-iomazenil SPECT in Alzheimer's disease.

Prohovnik I.

J Nucl Med. 1998 May;39(5):927. No abstract available.

38.

Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes.

Dwork AJ, Liu D, Kaufman MA, Prohovnik I.

Clin Neuropathol. 1998 Jan-Feb;17(1):45-9.

PMID:
9496540
39.

Diagnostic yield of brain CT in a limited-access environment.

Weiser M, Hendler T, Prohovnik I, Davidson M.

Int J Psychiatry Clin Pract. 1998;2(4):279-82. doi: 10.3109/13651509809115374.

PMID:
24927092
40.

Physostigmine reversal of scopolamine-induced hypofrontality.

Prohovnik I, Arnold SE, Smith G, Lucas LR.

J Cereb Blood Flow Metab. 1997 Feb;17(2):220-8.

PMID:
9040502
41.

Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease.

Keilp JG, Alexander GE, Stern Y, Prohovnik I.

Brain Cogn. 1996 Dec;32(3):365-83.

PMID:
8975677
42.

The economic burden of Alzheimer's disease in Israel.

Rothstein Z, Prohovnik I, Davidson M, Beeri MS, Noy S.

Isr J Med Sci. 1996 Nov;32(11):1120-3.

PMID:
8960086
43.

Acute effects of haloperidol on cerebral cortex blood flow in normal and schizophrenic subjects.

Goldman RG, Alexander GE, Zemishlany Z, Mukherjee S, Sackeim H, Prohovnik I.

Biol Psychiatry. 1996 Oct 1;40(7):604-8.

PMID:
8886293
44.

Discriminant value of semiquantitative SPECT data in mild Alzheimer's disease.

Prohovnik I.

J Nucl Med. 1996 Feb;37(2):404. No abstract available.

45.

Cortical blood flow and negative symptoms in schizophrenia.

Zemishlany Z, Alexander GE, Prohovnik I, Goldman RG, Mukherjee S, Sackeim H.

Neuropsychobiology. 1996;33(3):127-31.

PMID:
8776740
46.

Reliability of post-mortem chart diagnoses of schizophrenia and dementia.

Keilp JG, Waniek C, Goldman RG, Zemishlany Z, Alexander GE, Gibbon M, Wu A, Susser E, Prohovnik I.

Schizophr Res. 1995 Oct;17(2):221-8.

PMID:
8562497
47.

Radiation exposure to human trachea from xenon-133 procedures.

Prohovnik I, Metz CD, Atkins HL.

J Nucl Med. 1995 Aug;36(8):1458-61.

48.
49.

Possible utility of bilateral simultaneous TCD.

Prohovnik I.

J Cereb Blood Flow Metab. 1995 Jul;15(4):718. No abstract available.

PMID:
7790422
50.

Cerebral single-photon emission computed tomography abnormalities in human immunodeficiency virus type 1-infected gay men without cognitive impairment.

Sacktor N, Prohovnik I, Van Heertum RL, Dooneief G, Gorman J, Marder K, Todak G, Stern Y, Mayeux R.

Arch Neurol. 1995 Jun;52(6):607-11.

PMID:
7763210

Supplemental Content

Loading ...
Support Center